과제정보
Jigang Yang was supported by National Natural Science Foundation of China (No. 81971642,81771860), Beijing Natural Science Foundation (No. 7192041), National Key Research and Development Plan (No. 2020YFC0122000).
참고문헌
- Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol 2018;13:27-49 https://doi.org/10.1146/annurev-pathol-020117-043625
- Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer 2017;123:3229-3240 https://doi.org/10.1002/cncr.30826
- Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet 2014;383:1503-1516 https://doi.org/10.1016/S0140-6736(13)61048-X
- Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 2014;89:484-492 https://doi.org/10.1016/j.mayocp.2013.12.012
- Tabata C, Tabata R. Possible prediction of underlying lymphoma by high sIL-2R/ferritin ratio in hemophagocytic syndrome. Ann Hematol 2012;91:63-71 https://doi.org/10.1007/s00277-011-1239-7
- Li F, Li P, Zhang R, Yang G, Ji D, Huang X, et al. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China. Med Oncol 2014;31:902
- Jiang T, Ding X, Lu W. The prognostic significance of Beta2 microglobulin in patients with hemophagocytic lymphohistiocytosis. Dis Markers 2016;2016:1523959
- Yoon SE, Eun Y, Huh K, Chung CR, Yoo IY, Cho J, et al. A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study. Ann Hematol 2020;99:2095-2104 https://doi.org/10.1007/s00277-020-04083-6
- Zheng Y, Hu G, Liu Y, Ma Y, Dang Y, Li F, et al. The role of 18F-FDG PET/CT in the management of patients with secondary haemophagocytic lymphohistiocytosis. Clin Radiol 2016;71:1248-1254 https://doi.org/10.1016/j.crad.2016.05.011
- Yuan L, Kan Y, Meeks JK, Ma D, Yang J. 18F-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis. Diagn Interv Radiol 2016;22:471-475 https://doi.org/10.5152/dir.2016.15226
- Wang J, Wang D, Zhang Q, Duan L, Tian T, Zhang X, et al. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable. J Cancer Res Clin Oncol 2016;142:859-871 https://doi.org/10.1007/s00432-015-2094-z
- Kim J, Yoo SW, Kang SR, Bom HS, Song HC, Min JJ. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Ann Hematol 2014;93:661-667 https://doi.org/10.1007/s00277-013-1906-y
- Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-131 https://doi.org/10.1002/pbc.21039
- Cazzola M. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues. Blood 2016;127:2361-2364 https://doi.org/10.1182/blood-2016-03-657379
- Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood 2020;135:1332-1343 https://doi.org/10.1182/blood.2019000936
- La Rosee P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 2019;133:2465-2477 https://doi.org/10.1182/blood.2018894618
- Boddu P, Oviedo SP, Rausch CR, Yam C, Daver N, Kantarjian H, et al. PET-CT in AML-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2018;59:1486-1489 https://doi.org/10.1080/10428194.2017.1379079
- Shieh AC, Guler E, Smith DA, Tirumani SH, Beck RC, Ramaiya NH. Hemophagocytic lymphohistiocytosis: a primer for radiologists. AJR Am J Roentgenol 2020;214:W11-W19 https://doi.org/10.2214/AJR.19.21788
- Yang YQ, Ding CY, Xu J, Fan L, Wang L, Tian T, et al. Exploring the role of bone marrow increased FDG uptake on PET/CT in patients with lymphoma-associated hemophagocytic lymphohistiocytosis: a reflection of bone marrow involvement or cytokine storm? Leuk Lymphoma 2016;57:291-298 https://doi.org/10.3109/10428194.2015.1048442
- Merrill SA, Naik R, Streiff MB, Shanbhag S, Lanzkron S, Braunstein EM, et al. A prospective quality improvement initiative in adult hemophagocytic lymphohistiocytosis to improve testing and a framework to facilitate trigger identification and mitigate hemorrhage from retrospective analysis. Medicine (Baltimore) 2018;97:e11579
- Hao R, Yang X, Liu Z, Yang J. EBV-associated T-cell lymphoproliferative disorders demonstrated on FDG PET/CT in a patient with hemophagocytic lymphohistiocytosis. Clin Nucl Med 2019;44:829-830 https://doi.org/10.1097/RLU.0000000000002649
- Pan Q, Luo Y, Wu H, Ma Y, Li F. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis mimicking lymphoma on FDG PET/CT. Clin Nucl Med 2018;43:125-127 https://doi.org/10.1097/RLU.0000000000001923
- Lu J, Fang Q, Ma C, Su F, Chen G, Huang M, et al. Atypical Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis simulating lymphadenitis on 18F-FDG PET/CT and its differential diagnosis. Hell J Nucl Med 2017;20:254-257
- Zhang LJ, Xu J, Liu P, Ding CY, Li JY, Qiu HX, et al. The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis. J Hematol Oncol 2012;5:40
- Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005;117:104-111 https://doi.org/10.1016/j.clim.2005.08.004
- Deme D, Telekes A. Prognostic importance of plasma C-reactive protein (CRP) in oncology. Orv Hetil 2017;158:243-256 https://doi.org/10.1556/650.2017.30646
- Chen Y, Wang Z, Luo Z, Zhao N, Yang S, Tang Y. Comparison of Th1/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis. Ital J Pediatr 2016;42:50
- Ohno T, Ueda Y, Nagai K, Takahashi T, Konaka Y, Takamatsu T, et al. The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas. Int J Hematol 2003;77:286-294 https://doi.org/10.1007/BF02983788
- Xu XJ, Tang YM, Song H, Yang SL, Xu WQ, Zhao N, et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr 2012;160:984-990.e1 https://doi.org/10.1016/j.jpeds.2011.11.046
- Weiss ES, Girard-Guyonvarc'h C, Holzinger D, de Jesus AA, Tariq Z, Picarsic J, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood 2018;131:1442-1455 https://doi.org/10.1182/blood-2017-12-820852
- Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol 2014;93:821-826 https://doi.org/10.1007/s00277-013-1925-8
- Cronin CG, Swords R, Truong MT, Viswanathan C, Rohren E, Giles FJ, et al. Clinical utility of PET/CT in lymphoma. AJR Am J Roentgenol 2010;194:W91-W103 https://doi.org/10.2214/AJR.09.2637